BERWYN, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CLINICAL AND LABORATORY STANDARDS INSTITUTE, founded in 1969, is a community nonprofit in the Health Care sector that reported $8.3M in total revenue in fiscal year 2024. Revenue fell 24% from the prior year — a significant decline worth monitoring. Expenses of $7.8M left a modest 5% surplus.
THE MISSION OF CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI) IS TO "DEVELOP CLINICAL AND LABORATORY PRACTICES AND PROMOTE THEIR USE WORLDWIDE." WORKING TOGETHER, CLSI STAFF AND VOLUNTEER EXPERTS GUIDE THE DEVELOPMENT AND PROMOTE THE USE OF VOLUNTARY LABORATORY STANDARDS AND GUIDELINES WITHIN THE US AND INTERNATIONAL HEALTH CARE COMMUNITIES. CLSI FACILITATES A UNIQUE PROCESS OF DEVELOPING THESE TESTING STANDARDS BASED ON INPUT FROM AND CONSENSUS AMONG INDUSTRY, GOVERNMENT, AND HEALTH CARE PROFESSIONALS. IMPROVING THE QUALITY OF PATIENT CARE BY FOSTERING EXCELLENCE IN LABORATORY MEDICINE IS THE DRIVING FORCE BEHIND THE CREATION OF EVERY CLSI PRODUCT AND PROGRAM. FOUNDED IN 1968 AS A FOR-PROFIT STANDARDS DEVELOPMENT MEMBERSHIP ORGANIZATION, CLSI HAS EARNED THE CONFIDENCE AND RECOGNITION OF GOVERNMENT REGULATORY BODIES SUCH AS THE US FOOD AND DRUG ADMINISTRATION, CENTERS FOR DISEASE CONTROL AND PREVENTION, AND ORGANIZATIONS SUCH AS THE CENTERS FOR MEDICARE AND MEDICAID SERVICES THAT EITHER DIRECTLY ACCREDIT OR AUTHORIZE DEEMED STATUS ACCREDITATION STATUS. CLSI, ON BEHALF OF THE AMERICAN NATIONAL STANDARDS INSTITUTE, HAS SERVED FOR OVER 25 YEARS AS THE SECRETARIAT FOR THE INTERNATIONAL ORGANIZATION FOR STANDARDIZATION TECHNICAL COMMITTEE (TC 212) THAT AUTHORS GLOBAL STANDARDS FOR THE MEDICAL LABORATORY. CLSI IS FUNDED BY MEMBERSHIP DUES, THE SALES OF ITS PRODUCTS AND SERVICES, SPONSORSHIPS, AND GRANTS. CLSI STAFF, CONTRACTORS AND VOLUNTEERS PROVIDE SERVICES AND HANDS-ON SUPPORT TO LABORATORIES IN RESOURCE CONSTRAINED COUNTRIES, HELPING THEM ACHIEVE SUSTAINABLE QUALITY WITH SYSTEMS TO BETTER DIAGNOSE AND TREAT PATIENTS WITH INFECTIOUS DISEASES. THROUGH PARTNERSHIPS WITH THE US GOVERNMENT, UNIVERSITIES, AND OTHER NONPROFIT ORGANIZATIONS, CLSI HAS WORKED IN MORE THAN 20 COUNTRIES IN AFRICA, CENTRAL ASIA, SOUTH AMERICA, AND EASTERN EUROPE. FOR OVER 50 YEARS, OUR MEMBERS, VOLUNTEERS, AND CUSTOMERS HAVE MADE CLSI A RESPECTED, TRANSFORMATIVE LEADER IN THE DEVELOPMENT AND IMPLEMENTATION OF CLINICAL AND LABORATORY TESTING STANDARDS. THROUGH OUR UNIFIED EFFORTS, WE WILL CONTINUE TO SET AND UPHOLD THE STANDARDS THAT DRIVE QUALITY TEST RESULTS, ENHANCE PATIENTCARE DELIVERY, AND IMPROVE THE PUBLIC'S HEALTH AROUND THE WORLD.
THE DEVELOPMENT OF THE ORGANIZATION'S INTERNATIONAL OUTREACH INSTITUTE 23-7089361 CLINICAL AND LABORATORY STANDARDS INITIATIVE, THE GLOBAL HEALTH PARTNERSHIPS PROGRAM: CLSI STAFF AND VOLUNTEERS...
THE DEVELOPMENT OF THE ORGANIZATION'S INTERNATIONAL OUTREACH INSTITUTE 23-7089361 CLINICAL AND LABORATORY STANDARDS INITIATIVE, THE GLOBAL HEALTH PARTNERSHIPS PROGRAM: CLSI STAFF AND VOLUNTEERS PROVIDE TRAINING AND EDUCATION SERVICES AND HANDS-ON SUPPORT OF LABORATORIES IN RESOURCE-CONSTRAINED COUNTRIES, HELPING THEM ACHIEVE SUSTAINABLE QUALITY WITH SYSTEMS TO BETTER DIAGNOSE AND TREAT PATIENTS WITH INFECTIOUS DISEASES. THROUGH PARTNERSHIPS WITH THE US GOVERNMENT, UNIVERSITIES, AND OTHER NONPROFIT ORGANIZATIONS, CLSI HAS WORKED IN MORE THAN 20 COUNTRIES IN AFRICA, CENTRAL ASIA, CENTRAL AMERICA AND EASTERN EUROPE FOR OVER 50 YEARS, OUR MEMBERS, VOLUNTEERS AND CUSTOMERS HAVE MADE CLSI A RESPECTED, TRANSFORMATIVE LEADER IN THE DEVELOPMENT AND IMPLEMENTATION OF CLINICAL AND LABORATORY TESTING STANDARDS. THROUGH OUR UNIFIED EFFORTS, WE WILL CONTINUE TO SET AND UPHOLD THE STANDARDS THAT DRIVE QUALITY TEST RESULTS, ENHANCE PATIENT CARE DELIVERY, AND IMPROVE THE PUBLIC'S HEALTH AROUND THE WORLD.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $8,293,605 | $10,874,954 | -0.2% |
| Expenses | $7,839,242 | $8,518,162 | -0.1% |
| Net Income | $454,363 | $2,356,792 | -0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BARBARA J JONES | CEO AND BOARD MEMBER | 40.00 |
Officer
Director
|
$541,406 | $22,364 | $563,770 |
| LORIN BACHMANN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL LOEFFELHOLZ | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DEBRA KUEHL | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SUSAN SHARP | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| TANIA MOTSCHMAN | EX OFFICIO NON-VOTING MEMB | 1.00 |
Director
|
$0 | $0 | $0 |
| PAULA VAGNONE | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| GARY PROCOP | PRESIDENT ELECT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| VICTOR WADDELL | IMMEDIATE PAST PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LEONTHENA CARRINGTON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES NICHOLS | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOSEPH PASSARELLI | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| COLLETTE FITZGERALD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LORALIE J LANGMAN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| BARBARA L ZIMMER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER ADAMS | VP STANDARDS & QUALITY | 40.00 |
Key Emp
|
$236,422 | $23,291 | $259,713 |
| CECILIA PORTO | VP, FINANCE AND ACCOUNTING | 40.00 |
Key Emp
|
$235,768 | $26,802 | $262,570 |
| LISA ARONE | VP, GLOBAL COMMUNICATIONS | 40.00 |
Key Emp
|
$234,840 | $18,101 | $252,941 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $8,293,606 | $7,839,241 | $21,811,594 | $454,365 |
| 2025 | $8,293,605 | $7,839,242 | $21,811,594 | $454,363 |
| 2024 | $10,874,954 | $8,518,162 | $20,006,390 | $2,356,792 |
| 2023 | $9,966,525 | $8,831,659 | $19,023,956 | $1,134,866 |
| 2022 | $11,648,236 | $9,813,804 | $16,582,235 | $1,834,432 |
| 2021 | $9,183,918 | $7,120,673 | $16,915,959 | $2,063,245 |
| 2020 | $6,684,901 | $7,192,930 | $13,338,891 | $-508,029 |
| 2019 | $8,959,738 | $8,520,062 | $13,848,081 | $439,676 |
| 2018 | $9,379,193 | $8,320,985 | $12,942,871 | $1,058,208 |
Compare CLINICAL AND LABORATORY STANDARDS INSTITUTE with other nonprofits in Pennsylvania and across the country.